Page last updated: 2024-10-31

neostigmine and Hip Fractures

neostigmine has been researched along with Hip Fractures in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Hip Fractures: Fractures of the FEMUR HEAD; the FEMUR NECK; (FEMORAL NECK FRACTURES); the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region (FEMORAL FRACTURES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botero, C1
Smith, CE1
Morscher, AH1

Other Studies

1 other study available for neostigmine and Hip Fractures

ArticleYear
Anemia and perioperative myocardial ischemia in a Jehovah's Witness patient.
    Journal of clinical anesthesia, 1996, Volume: 8, Issue:5

    Topics: Adrenergic beta-Antagonists; Anemia; Anesthetics, Inhalation; Cholinesterase Inhibitors; Christianit

1996